Ramsay James G, Roizen Michael
Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Paediatr Anaesth. 2012 Oct;22(10):969-72. doi: 10.1111/pan.12014.
A history of the public-private partnership 'SmartTots' between the IARS and FDA is presented. In order to raise money for research to better understand the relationship between sedative and anesthetic agents and neurotoxicity in the developing brain, the FDA approached the IARS in 2008. A partnership was developed over the following 2 years, then a Scientific Advisory Board was created to develop a research agenda. The IARS contributed $200 000 in 2011 to provide initial funding; 33 proposals were submitted in response to a request for proposals in late 2011 and resulted in the awarding of two, $100 000 grants in 2012. An Executive Board was appointed under the leadership of Michael Roizen to spearhead additional fund-raising efforts, and a director of development is working with Dr. Roizen and the Board to raise funds from individuals and organizations. Dr. Roizen has personally committed to a matching grant for anesthesiologists, up to $50 000 per year for 20 years ($1 million). Readers of the journal are encouraged to go to the website www.smarttots.org in order to better understand the issue, to contribute to the research fund themselves, and to encourage their own professional organizations to partner with SmartTots in fund-raising.
本文介绍了国际麻醉研究学会(IARS)与美国食品药品监督管理局(FDA)之间公私合营的“智能宝宝”(SmartTots)项目的历史。为了筹集资金用于研究,以更好地了解镇静剂和麻醉剂与发育中大脑神经毒性之间的关系,FDA于2008年与IARS接洽。在接下来的两年里建立了合作关系,随后成立了一个科学顾问委员会来制定研究议程。IARS在2011年贡献了20万美元作为初始资金;2011年末针对提案征集提交了33份提案,并在2012年促成了两项金额各为10万美元的资助获批。在迈克尔·罗伊岑(Michael Roizen)的领导下任命了一个执行委员会来牵头开展更多的筹款工作,一名发展部主任正与罗伊岑博士及该委员会合作,从个人和组织那里筹集资金。罗伊岑博士个人承诺为麻醉医师提供等额赠款,为期20年,每年最高5万美元(总计100万美元)。鼓励该期刊的读者访问网站www.smarttots.org,以便更好地了解该问题,亲自为研究基金捐款,并鼓励自己所在的专业组织与“智能宝宝”合作进行筹款。